Gold at 4-Month Low amid Continuous Progress in Covid-19 Vaccine
George Lam November 24, 2020 3:07 AM
On Monday, spot gold dropped 1.8% to a 4-month low of $1,838, as sentiment was dampened by Covid-19 vaccine development.
On Monday, spot gold dropped 1.8% to a 4-month low of $1,838, as sentiment was dampened by Covid-19 vaccine development. Pharmaceutical giant AstraZeneca said its Covid-19 vaccine AZD1222 achieved an average efficacy of 70% and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine. This follow promising results from Pfizer's and Moderna's vaccines.
From a technical point of view, pressure is mounting on spot gold as shown on the daily chart. It has now broken below a bearish descending triangle pattern, and has probably confirmed the bearish evening star formed in early November. The level at $1,900 might be considered as the nearest resistance, while the 1st and 2nd support are expected to be located at $1,780 and $1,735 respectively.
Source: GAIN Capital, TradingView
Disclaimer: StoneX Financial Ltd (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
For further details see our full non-independent research disclaimer and quarterly summary.